冠状动脉疾病患者抗血小板治疗调整策略定义:学术研究联盟共识文件
该共识文件由学术研究联盟发布,旨在统一冠状动脉疾病患者抗血小板治疗调整策略的术语和定义。文件概述了降阶(de-escalation)和升阶(escalation)治疗的不同方式,以平衡血栓/缺血与出血风险,并提供标准化定义共识。
要点
- 抗血小板治疗调整包括降阶和升阶,可通过改变药物类型、剂量或数量实现。
- 共识提供标准化定义以解决术语混用问题,适用于接受PCI或药物治疗的CAD患者。
- 调整策略旨在平衡血栓/缺血事件与出血风险,需根据临床表现和个体因素选择。
核心结论
- 学术研究联盟共识提供了冠状动脉疾病患者抗血小板治疗调整策略的概述和标准化定义。
研究设计与样本
- 学术研究联盟(Academic Research Consortium)协作制定的共识文件。
主要发现
- 抗血小板治疗调整可通过降阶或升阶实现,涉及改变药物类型、剂量或数量。
- 降阶或升阶有多种新兴方法,术语常互换使用导致混淆。
关键数值与推荐
- 共识提供了不同抗血小板治疗调整策略的标准化定义。
临床怎么用
- 临床可根据患者临床表现和个体因素,选择降阶或升阶策略以平衡缺血与出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome. The use of antiplatelet therapy comes at the expense of an increased risk of bleeding complications. Defining the optimal intensity of platelet inhibition according to the clinical presentation of atherosclerotic cardiovascular disease and individual patient factors is a clinical challenge. Modulation of antiplatelet therapy is a medical action that is frequently performed to balance the risk of thrombotic or ischemic events and the risk of bleeding. This aim may be achieved by reducing (ie, de-escalation) or increasing (ie, escalation) the intensity of platelet inhibition by changing the type, dose, or number of antiplatelet drugs. Because de-escalation or escalation can be achieved in different ways, with a number of emerging approaches, confusion arises with terminologies that are often used interchangeably. To address this issue, this Academic Research Consortium collaboration provides an overview and definitions of different strategies of antiplatelet therapy modulation for patients with coronary artery disease, including but not limited to those undergoing percutaneous coronary intervention, and consensus statements on standardized definitions.
引用
- Capodanno, Mehran, Krucoff, et al. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023. PMID: 37335828. doi:10.1161/CIRCULATIONAHA.123.064473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。